ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Session » Poster Session 1

The 2020 Pediatric Rheumatology Symposium, originally scheduled for April 29 – May 2, was postponed due to COVID-19; therefore, abstracts were not presented as scheduled.

Date: Thursday, April 30, 2020

Time: 6:00PM-7:00PM

Meeting: 2020 Pediatric Rheumatology Symposium

6:00PM-7:00PM
Abstract Number: 053
Acceptability and Usability Testing of a Preliminary Version of the JIA Option Map, an Electronic Decision Aid for Pain Management Options in Juvenile Idiopathic Arthritis
6:00PM-7:00PM
Abstract Number: 169
Addressing the Pediatric Rheumatology Workforce Shortage: Is Early Exposure Enough?
6:00PM-7:00PM
Abstract Number: 072
Allogenic Hematopoietic Stem Cell Transplantation for Refractory Childhood Rheumatic Diseases
6:00PM-7:00PM
Abstract Number: 041
Ancestry, Demographic and Clinical Features of Israeli Periodic Fever Aphthous Stomatitis, Pharyngitis and Adenitis (PFAPA) Syndrome – a Multi-center Cohort
6:00PM-7:00PM
Abstract Number: 066
Baseline Kidney Biopsy in Lupus Patients Without Renal Manifestations. Underappreciated or Overrated?
6:00PM-7:00PM
Abstract Number: 059
Challenges Faced by Families of Children with an Auto-inflammatory Disease
6:00PM-7:00PM
Abstract Number: 054
Clinical and Laboratory Characteristics in Juvenile-onset Systemic Lupus Erythematosus Across Age Groups
6:00PM-7:00PM
Abstract Number: 170
Clinical Team Perspectives on the Transition from Pediatric to Adult Care for Patients with Childhood-Onset SLE
6:00PM-7:00PM
Abstract Number: 171
Development and Acceptability of an Adolescent Self-management Program for Juvenile Idiopathic Arthritis
6:00PM-7:00PM
Abstract Number: 068
Development of CARRA Consensus Treatment Plans for Severe ANCA-associated Vasculitis – Final CARRA-wide Consensus
6:00PM-7:00PM
Abstract Number: 151
Differences in Chromatin Architecture Between Treatment-Naïve Pediatric and Adult Lupus Patients
6:00PM-7:00PM
Abstract Number: 073
Differences in Clinical Presentation Between Israeli and United States Children with Juvenile Spondyloarthritis
6:00PM-7:00PM
Abstract Number: 055
Differential Analysis of Serum and Urine S100 Proteins in Juvenile-onset Systemic Lupus Erythematosus (jSLE)
6:00PM-7:00PM
Abstract Number: 153
Double Negative T Cells in Juvenile Dermatomyositis
6:00PM-7:00PM
Abstract Number: 074
Establishment of a Registry for Juvenile Idiopathic Arthritis (JIA) Patients in South Australia (SA): Focus on Patient Reported Outcome Measures (PROMs) and Experiences (PREMs)
6:00PM-7:00PM
Abstract Number: 152
Hemophagocytic Lymphohistiocytosis (HLH) Genetic Variants in Childhood-onset SLE (cSLE) with Macrophage Activation Syndrome (MAS)
6:00PM-7:00PM
Abstract Number: 076
How Do Pediatric Rheumatologists Diagnose Macrophage Activation Syndrome in Systemic Onset Juvenile Idiopathic Arthritis? An Examination of the CARRA Registry
6:00PM-7:00PM
Abstract Number: 173
Impact of a Nutrition-Focused Quality Improvement Intervention on Hospital Readmission Rates in Henoch-Schönlein Purpura with Gastrointestinal Involvement
6:00PM-7:00PM
Abstract Number: 172
Improved Self-efficacy and Knowledge in Pediatric Rheumatology Among General Pediatric Residents Following the Introduction of a Standardized Teaching Series
6:00PM-7:00PM
Abstract Number: 062
Is Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) a Reliable Tool for Detecting Vascular Activity in Treated Childhood-Onset Takayasu’s Arteritis (C-TA)? A Multicenter Study
6:00PM-7:00PM
Abstract Number: 058
Kawasaki Disease in Ontario Children from 1995-2017: A Population-based Descriptive Analysis
6:00PM-7:00PM
Abstract Number: 049
Levels of Anxiety and Depressive Symptoms in Juvenile Idiopathic Arthritis (JIA) and Their Correlation to Disease Manifestations Using Patient-Reported Outcomes Measurement Information System (PROMIS®) Measures
6:00PM-7:00PM
Abstract Number: 050
Long Term Safety of Biologics and Biosimilars in Pediatric Rheumatic Diseases: An Experience from a Single North Indian Centre
6:00PM-7:00PM
Abstract Number: 149
Low C4 Copy Number of Total C4 Gene, C4B Gene and C4BL Gene in Children with Pediatric Acute-onset Neuropsychiatric Syndrome (PANS)
6:00PM-7:00PM
Abstract Number: 063
Musculoskeletal Ultrasound Assessment in Pediatric Knee Hypermobility
6:00PM-7:00PM
Abstract Number: 044
Nailing Down Nailfold Capillaroscopy Practices: A Survey of Pediatric Rheumatologists Within the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Network
6:00PM-7:00PM
Abstract Number: 052
Nasopharyngeal Pneumococcus Colonization in Patients with Childhood Onset Systemic Lupus Erythematosus (cSLE) Compared to Healthy Controls
6:00PM-7:00PM
Abstract Number: 046
Near Infrared Indocyanine Green Imaging Reveals Altered Anatomy and Diminished Function in Lymphatic Vessels in the Hands of Rheumatoid Arthritis Patients During Flare
6:00PM-7:00PM
Abstract Number: 045
No-Shows: a Search for Modifiable Risk Factors
6:00PM-7:00PM
Abstract Number: 056
Non-criteria Antiphospholipid Antibodies Associated with Pediatric Rheumatic Disease: A Single-Center Case Series
6:00PM-7:00PM
Abstract Number: 048
Novel Algorithm to Increase Sensitivity of Detecting Active Arthritis in Children Through Infrared Thermal Imaging
6:00PM-7:00PM
Abstract Number: 060
Parsing Apart the Pain Experience: Exploring Treatment-Related Pain in Juvenile Idiopathic Arthritis
6:00PM-7:00PM
Abstract Number: 071
Patient Reported Outcomes and Resilience in Pediatric Systemic Lupus Erythematosus
6:00PM-7:00PM
Abstract Number: 047
Patients with Juvenile Idiopathic Arthritis in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry: Clinical Characteristics and Inception Cohorts
6:00PM-7:00PM
Abstract Number: 051
Pediatric Providers’ Perspectives on Suspected Immune-Mediated Diffuse Alveolar Hemorrhage and Clinical Care Pathways
6:00PM-7:00PM
Abstract Number: 061
Perspectives of Radiologist Physicians in the Imaging of Chronic Nonbacterial Osteomyelitis
6:00PM-7:00PM
Abstract Number: 065
Prosthetic Temporomandibular Joint Replacement in a Cohort of Adolescent Patients with Juvenile Idiopathic Arthritis
6:00PM-7:00PM
Abstract Number: 075
Pseudotumor Cerebri Syndrome in Children with Systemic Lupus Erythematosus
6:00PM-7:00PM
Abstract Number: 043
Resolution of Coronary Artery Changes in Patients with Refractory Kawasaki Disease with Prolonged Course of Infliximab: A Case Series
6:00PM-7:00PM
Abstract Number: 067
Response to Treatment with Intra-articular Triamcinolone Hexacetonide and Triamcinolone Acetonide in Oligo-articular Juvenile Idiopathic Arthritis
6:00PM-7:00PM
Abstract Number: 069
Rheumatic Fever in a Tertiary Medical Center – 25 Years of Follow Up
6:00PM-7:00PM
Abstract Number: 042
Safety Analysis of Infliximab-dyyb as Compared to Infliximab in Pediatric Rheumatic Conditions
6:00PM-7:00PM
Abstract Number: 064
The First 18 Months of a Pediatric Rheumatology Service at a Tertiary Referral Hospital in Kenya
6:00PM-7:00PM
Abstract Number: 070
The Importance of the Patient Global Health Assessment of Disease Activity in Polyarticular Juvenile Idiopathic Arthritis
6:00PM-7:00PM
Abstract Number: 150
The Killer Immunoglobulin-like Receptor KIR3DL1 in Combination with HLA-Bw4 Is Associated with Pediatric Acute-onset Neuropsychiatric Syndrome (PANS)
6:00PM-7:00PM
Abstract Number: 057
Transition from Pediatric to Adult Rheumatology: The Clinician as a Fundamental Ally

« View all sessions from this meeting

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology